InvestorsHub Logo
Post# of 252190
Next 10
Followers 833
Posts 119841
Boards Moderated 17
Alias Born 09/05/2002

Re: genisi post# 170018

Friday, 11/15/2013 7:49:12 AM

Friday, November 15, 2013 7:49:12 AM

Post# of 252190
The salient point is that GILD dropped GS-9669 in phase-3 trials, but has now resurrected GS-9669 in phase-2 trials. GILD clearly has a more positive viewpoint on the utility of a non-nuke in an all-DAA regimen, which is why I said they’re borrowing a page from ABBV/ENTA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.